Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells
Aide Negri(University of Parma), Federica Rizzi(University of Parma)
Cited by 12
Related Papers
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism
|Scientific Reports|2015|66